home / stock / ptie / ptie quote
Last: | $ |
---|---|
Change Percent: | 6.90% |
Open: | $1.19 |
Close: | $1.24 |
High: | $1.2699 |
Low: | $1.18 |
Volume: | 294,506 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $1.19 | $1.24 | $1.2699 | $1.18 | 294,506 | 03-27-2019 |
$ | $1.12 | $1.16 | $1.20 | $1.12 | 123,276 | 03-26-2019 |
$ | $1.19 | $1.14 | $1.19 | $1.12 | 260,356 | 03-25-2019 |
$ | $1.22 | $1.21 | $1.26 | $1.19 | 144,446 | 03-22-2019 |
$ | $1.26 | $1.22 | $1.28 | $1.20 | 209,742 | 03-21-2019 |
$ | $1.28 | $1.27 | $1.31 | $1.26 | 131,626 | 03-20-2019 |
$ | $1.30 | $1.28 | $1.33 | $1.25 | 159,399 | 03-19-2019 |
$ | $1.26 | $1.28 | $1.37 | $1.2455 | 851,437 | 03-18-2019 |
$ | $1.24 | $1.26 | $1.27 | $1.2101 | 162,960 | 03-15-2019 |
$ | $1.25 | $1.23 | $1.26 | $1.23 | 83,946 | 03-14-2019 |
$ | $1.25 | $1.26 | $1.27 | $1.22 | 144,462 | 03-13-2019 |
$ | $1.16 | $1.24 | $1.25 | $1.16 | 201,425 | 03-12-2019 |
$ | $1.19 | $1.17 | $1.20 | $1.16 | 94,405 | 03-11-2019 |
$ | $1.19 | $1.19 | $1.1985 | $1.14 | 124,094 | 03-08-2019 |
$ | $1.17 | $1.20 | $1.22 | $1.13 | 222,684 | 03-07-2019 |
$ | $1.25 | $1.18 | $1.2599 | $1.16 | 171,495 | 03-06-2019 |
$ | $1.25 | $1.25 | $1.3434 | $1.16 | 998,897 | 03-05-2019 |
$ | $1.18 | $1.20 | $1.20 | $1.1675 | 164,317 | 03-04-2019 |
$ | $1.19 | $1.20 | $1.21 | $1.16 | 171,397 | 03-01-2019 |
$ | $1.21 | $1.18 | $1.22 | $1.1325 | 85,954 | 02-28-2019 |
News, Short Squeeze, Breakout and More Instantly...
Pain Therapeutics Inc. Company Name:
PTIE Stock Symbol:
NASDAQ Market:
Pain Therapeutics Inc. Website:
AUSTIN, Texas, March 27, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a drug development company, announced a company name change to Cassava Sciences, Inc., effective immediately. The new name was chosen to better reflect the Company’s strategic focus on ...
AUSTIN, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today reported financial results for the year ended December 31, 2018. Net loss in 2018 was $6.6 million, or $0.61 per share, compared to a net loss in 2017 of $11.9 million, or $1.82 per share. Cash us...
AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug development company, today announced feedback from a meeting held January 31, 2019 with the U.S. Food and Drug Administration (FDA) regarding the drug candidate, REMOXY ER. R...